These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34156246)

  • 1. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
    Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
    Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.
    Koch V; Meschkov A; Feuerstein W; Pfeifer J; Fuhr O; Nieger M; Schepers U; Bräse S
    Inorg Chem; 2019 Dec; 58(23):15917-15926. PubMed ID: 31714764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
    Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
    Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
    Sangeetha S; Murali M
    Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Ir-N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes.
    Carrasco AC; Rodríguez-Fanjul V; Pizarro AM
    Inorg Chem; 2020 Nov; 59(22):16454-16466. PubMed ID: 33103884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
    Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
    Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear Luminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic Agents.
    Roy N; Sen U; Madaan Y; Muthukumar V; Varddhan S; Sahoo SK; Panda D; Bose B; Paira P
    Inorg Chem; 2020 Dec; 59(23):17689-17711. PubMed ID: 33210921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor Effects of Ir(III)-2
    Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
    Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.
    Li S; Xu G; Zhu Y; Zhao J; Gou S
    Dalton Trans; 2020 Jul; 49(27):9454-9463. PubMed ID: 32598409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.